02.1 Salt vs glycinate

Sodium molybdate vs molybdenum glycinate: the salt, the molybdenum and the fill

Technical document 02.1 · Reviewed 2026-11-19 · Sodium Molybdate

On this page
  1. Two different material classes
  2. The two forms side by side
  3. The molybdenum figure and the dose
  4. The fill and the blend
  5. The label and the permitted form
  6. When to choose which

Sodium molybdate is an inorganic salt that carries about 46% elemental molybdenum; molybdenum glycinate is a chelate whose molybdenum figure is declared by its supplier and usually sits in the low single digits. For the same molybdenum dose the chelate weighs roughly fifteen to twenty times more, which changes the blend step, the label and, at higher doses, the fill.

In one line

The salt carries about 46% molybdenum and the glycinate a few percent, so a switch changes the mass per dose, the blend step and the ingredient name rather than only the powder.

Two different material classes

Sodium molybdate is an ionic salt with a fixed formula, Na2MoO4, a fixed molar mass and a molybdenum figure that follows from the formula. It dissolves freely in water and is assayed as a salt. Molybdenum glycinate, often described as a bisglycinate chelate, binds molybdenum to glycine; the commercial material is a chelate on a carrier, and its molybdenum content is a declared assay rather than a formula constant.

That difference decides how each material is specified. The salt can be bought against a CAS number, a stoichiometric molybdenum range and a loss-on-drying limit. The chelate has to be bought against the supplier's declared molybdenum figure, the ligand and carrier, and the method used to measure the element. The word glycinate does not fix the assay, and the word molybdate does not fix the hydrate.

The two forms side by side

Sodium molybdate against molybdenum glycinate
PropertySodium molybdateMolybdenum glycinate
Chemical typeInorganic saltAmino-acid chelate
CAS number10141-05-6 (anhydrous)— (supplier-specific material)
FormulaNa2MoO4Not a single stoichiometric formula
Molybdenum45.0–47.0%Declared; low single digits typical
SodiumAbout 22.3%None from the chelate
Water solubilityFreely solubleCarrier- and chelate-dependent
Release assayHPLC and complexometric titrationSupplier method, usually total molybdenum
Label nameSodium molybdateMolybdenum glycinate chelate

The CAS row is a purchasing issue. The salt has one CAS number for the anhydrous form and another for the dihydrate, and either one can be specified. The chelate is a trade material, so its certificate, not its name, carries the molybdenum figure. An order that names molybdenum glycinate without a molybdenum specification has not fixed the material.

The molybdenum figure and the dose

The label declares elemental molybdenum, so the compound mass per dose is the declared figure divided by the molybdenum fraction. The salt's fraction is fixed at about 46.6%; the chelate's comes from its certificate. The table uses 2.5% and 5% as examples of commercial chelate figures; the certificate replaces the example.

Compound mass for a target molybdenum dose
Elemental molybdenumSodium molybdate (46.6%)Glycinate at 2.5%Glycinate at 5%
50 µgAbout 107 µgAbout 2.0 mgAbout 1.0 mg
100 µgAbout 215 µgAbout 4.0 mgAbout 2.0 mg
500 µgAbout 1,073 µgAbout 20 mgAbout 10 mg

At 100 µg the salt is 215 µg of powder and a 2.5% chelate is 4 mg: an eighteen-fold difference. At 500 µg the salt is about 1.07 mg and the same chelate is 20 mg. The elemental dose is identical, but the weighing range, the premix ratio and the label declaration are not. A formulation copied from one form to the other without redoing that arithmetic will miss the declared dose.

The fill and the blend

At these masses the molybdenum source is a minor part of a capsule. A 500 mg fill holds 215 µg of salt for a 100 µg dose, which is 0.04% of the fill, or 4 mg of a 2.5% chelate, which is 0.8%. Neither form fills the capsule, and the capsule size is normally set by the other ingredients. The switch changes the premix, not the fill weight.

Blend uniformity is the real constraint. A 0.04% ingredient cannot be weighed into each capsule, so the salt is usually handled as a trituration or a granulated dilution; a 1% salt blend puts 21.5 mg in the capsule for a 100 µg dose. The chelate can be blended at 0.8% directly in some processes, but it still needs a premix for a production batch. The premix carrier, the dilution ratio and the uniformity data all change with the form.

At higher doses the fill does move. A 500 µg dose is 1.07 mg of salt but 20 mg of a 2.5% chelate; at a multi-milligram dose the chelate starts to take real space in the capsule. The salt also brings sodium: 1.07 mg of salt carries about 0.24 mg of sodium, which is small against a diet but is part of the ingredient line. The same low-dose blending question appears with sodium selenite and copper gluconate, where the elemental figure, not the compound weight, sets the premix.

The label and the permitted form

The ingredient line has to name the material that was weighed. Sodium molybdate and molybdenum glycinate chelate are different declarations, and a change of source is a label change even when the elemental molybdenum figure is adjusted to match. The sodium contribution belongs on the label with the salt and not with the chelate.

The destination's permitted-forms list is the second check. The salt name and the chelate name are separate entries or separate questions, and the buyer's regulatory team confirms that the form on the label appears on the current list for the market. A file written around one form does not automatically cover the other, and an assay result does not settle a labelling question.

This page makes no disease-related claim for either form. The claim review is separate from the identity of the ingredient, and it is done by the brand's regulatory reviewer for the finished product and the market.

When to choose which

Choose the salt when the specification should be fixed by a formula and a CAS number, when the dose is small enough that the powder mass is irrelevant, and when the label names the inorganic salt. It is the catalog form here: anhydrous sodium molybdate, 45.0–47.0% molybdenum, freely soluble, with a defined release assay. The product hub carries that specification, and the grades page covers the hydrate and mesh choices.

Choose the chelate when the formula or the label calls for a chelate and the market file covers that form. Specify the molybdenum figure, the ligand and carrier, the assay method and the particle size, and check the permitted-form list before the label is written. A switch in either direction needs a written change control, a new specification and a label review.

The analytical methods that separate the forms are set out in the methods library; the release and retention workflow is on the quality page. Neither form is a drop-in for the other, and the molybdenum figure is the number that makes the difference visible.

Send the specification you intend to use — grade, quantity and destination market — and we will reply with the batch COA, the technical data sheet and a quotation.

Request a quotation